RNS Number : 8426O
Pristine Capital PLC
30 June 2025
 

Pristine Capital Plc / EPIC: PRIS / Market: LSE

 

 

30 June 2025

 

PRISTINE CAPITAL PLC

("Pristine" or the "Company")

 

Unaudited interim results

 

Pristine Capital Plc, the Main Market cash shell focusing on the real estate sector, is pleased to announce its unaudited interim results for the six months ended 30 April 2025.

 

Chairman's statement

 

I am pleased to present Pristine's unaudited interim results to shareholders.

 

As stated in our Annual Report for the year ended 31 October 2023, in February 2024, Stanley Davis, Andrew Perloff and I, through our various interests, subscribed for 31,240,000 new ordinary shares in the Company at an issue price of 1p, which raised £312,240 for the Company. Our intention has been to identify a Reverse Takeover in the Real Estate sector, by successfully acquiring a distressed commercial property portfolio or a distressed significant single asset.

 

As announced on 27 June 2025, the Company has signed non-binding heads of terms for the proposed acquisition of a regional property portfolio in the United Kingdom (the "Property Portfolio") for c. £20 million (the "Proposed Acquisition"). The Property Portfolio, which comprises three office properties, is income generating and let to quality tenants. The Proposed Acquisition is expected to be financed through a mixture of equity and debt secured on the Property Portfolio and we have signed a credit committee approved term sheet for the debt, subject to valuation, legal formalities and completion of the Proposed Acquisition.

 

The Proposed Acquisition is conditional, inter alia, on entering into a binding acquisition agreement with the vendor and will be accompanied by a fundraise via an issue of new ordinary shares by the Company (the "Fundraise") to pay the cash consideration for the Proposed Acquisition and the associated fees and finance the ongoing activities of the Company, as enlarged by the Proposed Acquisition. 

 

Due to the anticipated market capitalisation of the Company, as enlarged by the Proposed Acquisition, it is intended that the Company will cancel the listing of its shares on the Main Market of the London Stock Exchange and seek admission of its shares to trading on AIM.

 

There has been extensive media comment, both in the financial and property press, that a real estate company needs to be of sufficient scale to attract investors. I have been extensively pointing out both to the media and investors that this really is a misnomer. There may be a liquidity issue with smaller public companies, but the fact is that a number of leading companies in the real estate sector have a market capitalisation which is no larger than it was 25 years ago. However, a number of smaller companies have multiplied their market capitalisation by more than fifteen-fold and have produced greater returns for their shareholders. We are confident that the current macroeconomic environment provides a particularly attractive entry point in the cycle.

 

The Board looks forward to updating the Company's shareholders in due course.

 

Financials

The Company reported a loss, for the six-month period ended 30 April 2025 of £98,902 (six months ended 30 April 2024: loss of £141,246). The Company's net cash balance as at 30 April 2025 was £666,564 (30 April 2024: £813,416).

 

 For further information please visit www.pristinecapitalplc.com or contact:

Pristine Capital plc

Neil Sinclair, Executive Chairman

 

 

Tel: +44 (0) 20 3988 0227

 

Allenby Capital Limited (Broker)

Nick Naylor/James Reeve/Lauren Wright (Corporate Finance)

Guy McDougall (Sales & Corporate Broking)

 

Tel: +44 (0)20 3328 5656

RMS Partners (Investor Relations)

Simon Courtenay

 

Tel: +44 (0) 20 3735 6551

 

 

 

Responsibility statement

 

We, the Directors of the Company, confirm that to the best of our knowledge: 

 

· the interim financial statements have been prepared in accordance with International Accounting Standards 34, Interim Financial Reporting, as adopted by the UK;

· give a true and fair view of the assets, liabilities, financial position and loss of the Company; and

· the Interim report includes a fair review of the information required by DTR 4.2.7R of the Disclosure and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the set of interim financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

The interim report was approved by the Board of Directors and the above responsibility statement was signed on its behalf by:

 

 

 

Neil Sinclair

Executive Chairman

30 June 2025

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

Notes

6 months to 30 April 2025 Unaudited

£

12 months to 31 October 2024 Audited 

£

6 months to 30 April 2024 Unaudited

£

 

Administration expenses

(104,297)

(196,987)

(125,467)

Share based payment

-

(45,000)

-

Warrant expense

-

(44,056)

(15,779)

Operating loss before tax

(104,297)

(286,043)

(141,246)

Finance income

5,395

1,259

-

Loss before income tax

(98,902)

(284,784)

(141,246)

Income tax

-

-

-

Loss after tax and total comprehensive income for the period

 

(98,902)

(284,784)

(141,246)

 

 

 

Loss per share

Basic (pence per share)

5

(0.06)p

(0.19)p

(0.10)p

 

 

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

 

 

 

 

Notes

As at

30 April 2025 Unaudited

£

As at

31 October 2024 Audited

£

As at

30 April 2024 Unaudited

£

Current Assets

 

Trade and other receivables

34,529

50,678

79,627

Cash and cash equivalents

666,564

764,364

813,416

701,093

815,042

893,043

Total Assets

701,093

815,042

893,043

 

 

Current Liabilities

 

Trade and other payables

(11,017)

(26,064)

(33,805)

 

(11,017)

(26,064)

(33,805)

Total Liabilities

(11,017)

(26,064)

(33,805)

Net Assets

690,076

788,978

859,238

Capital and Reserves

 

Share capital

6

1,607,241

1,607,241

1,607,241

Cost of capital

6

-

-

(45,000)

Warrant reserve

7

862,448

862,448

834,171

Retained losses

(1,779,613)

(1,680,711)

(1,537,174)

Total Equity

690,076

788,978

859,238

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Share capital

£

Cost of capital

£

Other reserves

£

Retained losses

£

Total equity

£

Balance as at 1 November 2023

 

1,250,001

-

818,392

(1,395,928)

672,465

Loss for the period

-

-

-

(141,246)

(141,246)

Total comprehensive income for the year

 

-

-

-

(141,246)

(141,246)

Shares issued during the year

 

357,240

-

-

-

357,240

Cost of issuing shares

 

-

(45,000)

-

-

(45,000)

Warrants issued in period

 

-

-

15,779

-

15,779

Total transactions with owners, recognised in equity

 

357,240

(45,000)

15,779

-

328,019

Balance as at 30 April 2024

 

1,607,241

(45,000)

834,171

(1,537,174)

859,238

 

 

 

 

 

 

 

Balance as at 1 November 2024

 

1,607,241

-

862,448

(1,680,711)

788,978

Loss for the period

-

-

-

(98,902)

(98,902)

Total comprehensive income for the year

 

-

-

-

(98,902)

(98,902)

Balance as at 30 April 2025

 

1,607,241

-

862,448

(1,779,613)

690,076

 

 

 

 

 

 

 

 

 

 

 

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

 

 

 

 

 

Notes

6 months to 30 April 2025

Unaudited

£

6 months to 30 April 2024

Unaudited

£

Cash flows from operating activities

 

 

Loss before taxation

(98,902)

(141,246)

Adjustments for:

Warrant expense

-

15,779

Net finance income

(5,395)

-

Decrease/(increase) in trade and other receivables

16,149

(16,057)

(Decrease) in trade and other payables

(15,047)

(6,566)

Net cash used in operations

(103,195)

(148,090)

Cash flows from financing activities

 

Proceeds from share issue

-

357,240

Cost of share issue

-

(45,000)

Net cash generated from financing activities

-

312,240

Cash flows from investing activities

 

Interest paid

5,395

-

Net cash generated from investing activities

5,395

-

Net decrease in cash and cash equivalents

(97,800)

164,150

Cash and cash equivalents at beginning of period

764,364

649,266

Cash and cash equivalents at end of period

666,564

813,416

 

 

 

 

NOTES TO THE INTERIM FINANCIAL STATEMENTS

 

1. General Information

 

Pristine Capital Plc (the "Company") is a public limited company incorporated and domiciled in the United Kingdom. The address of its registered office is 42 Upper Berkeley Street, London W1H 5QL with registered number 13628889.

 

The Company was formed on 17 September 2021 as a cash shell with the aim to undertake one or more acquisitions, which may be in the form of a merger, capital stock exchange, asset acquisition, stock purchase or a scheme arrangement of a majority interest in a company or business. The Company shares were admitted to trading on the Standard List of the Main Market on the London Stock Exchange on 4 March 2022. It is now intended that the Company will focus on doing a transaction in the Real Estate Sector.

The Company formally changed its name from More Acquisitions Plc to Pristine Capital Plc on 10 June 2024.

 

 2. Basis of Preparation

 

These condensed interim financial statements are for the six months ended 30 April 2025 and have been prepared in accordance with the accounting policies adopted in the Company's most recent annual financial statements for the year ended 31 October 2024.

 

The Company has chosen to adopt IAS 34 "Interim Financial Reporting" in preparing this interim financial information as adopted by the United Kingdom and the Disclosure and Transparency Rules of the UK Financial Conduct Authority. They do not include all the information required in annual financial statements, and they should be read in conjunction with the financial statements for the year ended 31 October 2024 and any public announcements made by Pristine Capital Plc during the interim reporting period.

 

The interim financial information set out above does not constitute statutory accounts within the meaning of the Companies Act 2006. It has been prepared on a going concern basis in accordance with the recognition and measurement criteria of International Financial Reporting Standards (IFRS) as adopted by the United Kingdom.

 

Statutory financial statements for the period ended 31 October 2024 were approved by the Board of Directors on 21 February 2025 and delivered to the Registrar of Companies. The report of the auditors on those financial statements was unqualified. The condensed interim financial statements are unaudited and have not been reviewed by the Company's auditor. 

 

Going concern

 

The Directors, having made appropriate enquiries, consider that adequate resources exist for the Company to continue in operational existence for the foreseeable future and that, therefore, it is appropriate to adopt the going concern basis in preparing the condensed interim financial statements for the period ended 30 April 2025.

 

Risks and uncertainties

 

The Board continuously assesses and monitors the key risks of the business. The key risks that could affect the Company's medium term performance and the factors that mitigate those risks have not substantially changed from those set out in the Company's 2024 Annual Report and Financial Statements, a copy of which is available on the Company's website: www.pristinecapitalplc.com. The key financial risks are market risk, liquidity risk and interest rate risk.

 

Critical accounting estimates

 

The preparation of condensed interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the end of the reporting period. Significant items subject to such estimates are set out in Note 1 of the Company's 2024 Annual Report and Financial Statements. The nature and amounts of such estimates have not changed significantly during the interim period.

 

3. Accounting Policies

 

A number of new standards and amendments became effective on 1 January 2025 and have been adopted by the Company. None of these standards have materially affected the Company.

 

The same accounting policies, presentation and methods of computation are followed in the interim financial information as were applied in the Company's latest annual audited financial statements except for those that relate to new standards and interpretations effective for the first time for periods beginning on (or after) 1 January 2025 and will be adopted in the 2025 annual financial statements. 

 

 

 

 

 

 

 

4. Dividends

 

No dividend has been declared or paid by the Company during the six months ended 30 April 2025 (six months ended 30 April 2024: £nil).

 

5. Loss per Share

The calculation of loss per share is based on a retained loss of £98,902 for the six months ended 30 April 2025 (six months ended 30 April 2024: loss £141,246) and the weighted average number of shares in issue in the period ended 30 April 2025 of 160,724,100 (six months ended 30 April 2024: 144,628,671).

 

No diluted earnings per share is presented for the six months ended 30 April 2025 or six months ended 30 April 2024 as the effect on the exercise of share options would be to decrease the loss per share.

 

6. Share capital and cost of capital

 

 

Company

 

Number of shares

 

No.

Nominal value

£

Ordinary shares

160,724,100

0.01

1,607,241

Total

160,724,100

 

1,607,241

 

 

 

Issued at 0.01 pence per share

Number of Ordinary shares

Share capital

£

Total

£

 

As at 31 October 2024

160,724,100

1,607,241

 1,607,241

As at 30 April 2025

160,724,100

1,607,241

1,607,241

 

 

 

7. Events after the balance sheet date

There are no post balance sheet events.

 

8. Approval of interim financial statements

The Condensed interim financial statements were approved by the Board of Directors on 30 June 2025.

 

**ENDS**

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BLGDLRDDDGUR